“…Using these models, researchers have been able to identify abnormalities in PMCA activity in a number of disease states (28, 291). In addition, purified preparations of human erythrocyte PMCA have been widely used to identify molecular and pharmacological modulators of the pumps' activity such as F-and G-actin, acidic phospholipids, diacylglycerol, the bidentate chromium (III) ATP complex, the phytoalexin resveratrol, and inhibitory peptide caloxin1c2 (251,263,277,278,289,383).…”